Life sciences software & AI news

Showing 1000+ results

Aug 27, 2026

SpendRule Names Health System Transformation Leader Beth Graefe, EdD, as Strategic Advisor

Veteran of more than 100 hospital margin improvement initiatives joins SpendRule's Advisory Board as the healthcare industry confronts mounting pressures to reduce costsDALLAS, Aug. 27, 2026 /PRNewswire/ -- SpendRule, healthcare's first AI-native contract-to-payment integrity platform, today announced that Beth Graefe, EdD, joins the company as a strategic advisor. Graefe will guide SpendRule's growth strategy and deepen its alignment with health system supply chain and finance priorities as the

Aug 27, 2026

Press release

UPMC Expands AI-Native Clinical Services to 18 Hospitals This Fall

Andor Health and Psynergy Health jointly own the outcome with UPMC to deliver transitional care management alongside clinical teams, from the AI infrastructure through the clinicians providing the care. The program is live in 10 UPMC hospitals today, with 8 more joining this fall.ORLANDO, Fla., Aug. 27, 2026 /PRNewswire/ -- UPMC has expanded an AI-native clinical services model in transitional care management to 10 of its hospitals, with one more launching September 1 and seven more on September

Aug 27, 2026

Press release

UT Medical and TransformativeMed Partner to Develop AgenticAI Discharge Planning

Partners to showcase their jointly developed solution at the Oracle Health SummitSEATTLE, Aug. 27, 2026 /PRNewswire/ -- UT Medical and TransformativeMed today announced a development partnership focused on Agentic Discharge Planning, a solution the organizations are building together to transform one of the most complex and resource-intensive processes in acute care. This represents the latest innovation of the CORES Platform, an Agentic Clinical Operating System.Continue Reading

Aug 27, 2026

Press release

FDA Inspection Data Reveals a New Compliance Blind Spot for Medical Device Makers

As the FDA deploys AI to analyze submissions at scale, the first QMSR inspection cycle shows problems are spreading across entire quality systems, not just single departmentsSALT LAKE CITY, Aug. 27, 2026 /PRNewswire/ -- Newly surfaced inspection data from the first months of the FDA's Quality Management System Regulation (QMSR) shows a tough new reality for life sciences teams: investigators are no longer looking at procedural gaps in isolation. Instead, they're uncovering interconnected problem

Aug 27, 2026

Press release

Neurophet Supplies 'Neurophet AQUA' and 'Neurophet AQUA AD Plus' to Elevate Clinic in the U.S., Expanding Its Presence in the U.S. Brain Disorders Market

Provides solutions for analyzing brain atrophy and white matter hyperintensities, as well as monitoring side effects associated with Alzheimer's disease treatmentsSecures a key reference site at a U.S. medical institution specializing in neurological disorders, accelerating product adoption across major healthcare institutions in North AmericaSEOUL, South Korea, Aug. 27, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company

Aug 27, 2026

Press release

Elsevier makes new "Ask AI" Feature in ClinicalKey available to more than 1,500 hospital sites in the US

"Ask AI" delivers direct, cited answers to clinical questions grounded exclusively in ClinicalKey's evidence-based content, including books, journals, and clinical guidelines.NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Elsevier today announced the launch of "Ask AI," a new generative AI feature integrated within ClinicalKey, its flagship clinical decision support solution for physicians. ClinicalKey's Ask AI gives clinicians a direct, conversational way to ask clinical questions and receive concise

Aug 27, 2026

Press release

Maven Members with High-Risk Pregnancies See 32% Fewer NICU Admissions

New research from the Maven Clinical Research Institute finds lower rates of two of maternity care's most consequential complicationsNEW YORK, Aug. 27, 2026 /PRNewswire/ -- Maven Clinic, the world's largest virtual clinic for women and families, today announced new research from the Maven Clinical Research Institute showing that Maven members with high-risk pregnancies had 32% fewer NICU admissions and 10% fewer C-sections than a national benchmark—two of the costliest complications in maternity

Aug 27, 2026

Press release

Wellness Insights in Your Hands in 60 Seconds: EYVA to Introduce Unique Touch-Based Metabolic Wellness Tracker to U.S. Market - EYVA Pro

The EYVA Pro experience brings together six key wellness indicators with personalized AI-powered insights to help consumers explore the bigger picture across their metabolic, cardiovascular, and respiratory wellnessHYDERABAD, India, Aug. 27, 2026 /PRNewswire/ -- What if gaining a better understanding of your everyday wellness began simply with placing your thumbs on a device for 60 seconds?This is the powerful concept behind EYVA (EYVA.io), an innovative wellness technology company that has alre

A minimalist illustration of a clipboard and pen, symbolizing documentation in healthcare.

Aug 27, 2026

Ardent Health finds ambient AI's value goes beyond ROI

Ardent Health has achieved significant milestones with its ambient AI technology, surpassing one million patient encounters since its launch last September. This deployment has demonstrated an impressive 87% utilization rate among clinicians, leading to substantial time savings in documentation and improved coding accuracy.The chief medical information officer, Dr. Brad Hoyt, emphasizes that the value of ambient AI extends beyond mere financial metrics. While the system has shown a threefold ret

Aug 27, 2026

Press release

Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a new Signatera collaboration with Angiex, Inc., a privately held biotech company developing a portfolio of Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs).Angiex is conducting a Phase I clinical trial of AGX101, an investigational TM4SF1-directed ND-ADC. AGX101 is designed to bind TM4SF1 and deliver a cytotoxic payload to TM4SF1-expressing tumor cells and t

Aug 27, 2026

Press release

Velocity Clinical Research Establishes a New Industry Benchmark, Entering 97% of Patient Data Within 24 Hours of Collection

Centralized data model cuts industry-standard entry times by 80% with 99% confirmed accuracySponsors receive rapid access to clinical data and resolved queries for faster decision making DURHAM, N.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Velocity Clinical Research, the world's largest integrated global site network, today announced that its centralized Electronic Data Capture (EDC) model is now entering 97% of clinical trial data within one business day of patient visits — two to four days faster

Aug 27, 2026

Press release

ProFound Therapeutics Receives Investment to Tackle Preeclampsia and Eclampsia

Up to $35 million from the Gates Foundation will support ProFound's use of its platform, datasets, and algorithms to identify new drug targets and biomarkers for preeclampsia and eclampsiaCAMBRIDGE, Mass., Aug. 27, 2026 /PRNewswire/ -- ProFound Therapeutics, a Flagship Pioneering company harnessing the expanded human proteome to develop first-in-class medicines for multiple diseases, today announced that it has received an investment commitment of up to $35 million from the Gates Foundation, inc

Back to start
Previous
Page 46 of 84
Next

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Platform

Legal